Brief: Amicus Therapeutics Announces Approval, Launch Of New Pompe Disease Therapy In The European Union
June 27 (Reuters) - Amicus Therapeutics Inc FOLD.O :
* AMICUS THERAPEUTICS ANNOUNCES APPROVAL AND LAUNCH OF NEW
POMPE
DISEASE THERAPY IN THE EUROPEAN UNION
Source text for Eikon: ID:nGNX9y8PRF
Further company coverage: FOLD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates